Claris Ltd. (Claris) is a holding company established with a long-term objective of diversifying to multiple businesses, driven by the spirit of innovation & desire to make sustainable impact. Powered by our experience in building large scale global healthcare businesses from scratch, efficiently & quickly, Claris has pivoted itself for new growth & opportunity through investments & management interest in the fields of Clean Energy, Venture Capital & Incubators. Our genesis dates to 1999 with Claris Lifesciences, a healthcare company with focus on infusions and specialty injectables. At its peak, the infusions business, had more than 50% market share in the IV fluids segment. In the Injectables space, Claris was one of the largest pure-play sterile generic injectable companies in India, with approvals from the most stringent regulatory bodies in the world like US FDA, MHRA (UK) and TGA (Australia), among others. In a span of two decades, the company created nearly billion-dollar valuation, established world-class integrated business model, introduced over 130 products, built presence in over 100 countries, had a team of over 4,000, and was listed on the Bombay Stock Exchange. Claris exited healthcare in 2017, after sale of injectables business to Baxter and infusions business to Otsuka and Mitsui. At the helm since 2008, Vice Chairman and MD Arjun Handa brought accelerated growth that saw Claris leverage cutting-edge manufacturing capabilities. As a former national-level football player the lessons Arjun learnt on the pitch, from team spirit to perseverance, have reflected in his ability to strategize, inspire and lead. Our commitment to a people-centric culture has helped Claris win ‘India’s Best Companies To Work For’ award, 8 years in a row. Parallel to striving for excellence, Claris serves as a socially responsible organization by supporting and encouraging various social causes in the area of sports and fitness, business and entrepreneurship, art and culture.